Home
Lecanemab and the new potential of anti-abeta therapies for Alzheimer's
The Lab Mouse
Mar 8, 2024
1,013 views
Leqembi Webinar Sept 2023
A Closer Look at Lecanemab, Donanemab and Amyloid
Mechanism explained- CRISPR Drug for Sickle Cell Anemia (Casgevy)
New Alzheimer's drug offers hope to patients and caregivers | DW News
What’s New in Alzheimer’s Disease Clinical Trials?
Comparison of Checkpoint Inhibitor-Induced Liver Injury With Autoimmune Hepatitis |John Vierling, MD
Research Reveals: This Repairs Nerve Damage
Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Rohit Loomba, MD
Lecanemab: FDA Approved for Early Alzheimer's Disease
Diet and Nutrition 1 - BrainMind Alzheimer's Prevention Series
Disease-modifying treatments for Alzheimer's disease | Prof Colin Masters from The Florey
The FDA cares about biomarkers now (how NfL got Tofersen approved)
Dementia treatment l Acetylcholinesterase inhibitors | Donepezil, Galantamine, Rivastigmine
APOE Gene Variants & Alzheimer’s Disease Risk: details you should know
11th Annual Parkinson's Disease Symposium | Medication Updates
How effective is Lecanemab?
Lecanemab - a breakthrough in treating Alzheimer´s disease?
Diet and Nutrition 2 - BrainMind Alzheimer's Prevention Series
How soon could lecanemab be prescribed to treat Alzheimer's?
Tau Protein Pathology in Alzheimer's Disease